SPIRONOLACTONE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 17856-1133
  • Package NDC 17856-1133-1
  • Package NDC 17856-1133-4
  • Package NDC 17856-1133-5
  • Package NDC 17856-1133-6
  • Package NDC 17856-1133-7
  • Package NDC 17856-1133-8
  • Application number NDA209478
  • SPL ID 59f7927f-899d-3af9-e063-6394a90aacbd
  • SPL set ID 122558a0-57bb-4195-9adf-d37b049cbfb5
  • UNII 27O7W4T232
  • RxCUI 104232

What the source publishes

Labeler
ATLANTIC BIOLOGICALS CORP.
Active ingredients
spironolactone
Form
SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:17856-1133_59f7927f-899d-3af9-e063-6394a90aacbd
{
  "name": "SPIRONOLACTONE",
  "splId": "59f7927f-899d-3af9-e063-6394a90aacbd",
  "labels": [
    {
      "setId": "122558a0-57bb-4195-9adf-d37b049cbfb5",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=122558a0-57bb-4195-9adf-d37b049cbfb5",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=122558a0-57bb-4195-9adf-d37b049cbfb5"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "ATLANTIC BIOLOGICALS CORP.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SYRINGE in 1 BAG (17856-1133-1)  / 2.5 mL in 1 SYRINGE (17856-1133-3)",
      "package_ndc": "17856-1133-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240603"
    },
    {
      "sample": false,
      "description": "1 SYRINGE in 1 BAG (17856-1133-4)  / 2.5 mL in 1 SYRINGE (17856-1133-2)",
      "package_ndc": "17856-1133-4",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250926"
    },
    {
      "sample": false,
      "description": "120 SYRINGE in 1 CASE (17856-1133-5)  / 1 mL in 1 SYRINGE",
      "package_ndc": "17856-1133-5",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260430"
    },
    {
      "sample": false,
      "description": "120 SYRINGE in 1 CASE (17856-1133-6)  / 3 mL in 1 SYRINGE",
      "package_ndc": "17856-1133-6",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260430"
    },
    {
      "sample": false,
      "description": "1 SYRINGE in 1 BAG (17856-1133-7)  / 1 mL in 1 SYRINGE",
      "package_ndc": "17856-1133-7",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260702"
    },
    {
      "sample": false,
      "description": "1 SYRINGE in 1 BAG (17856-1133-8)  / 3 mL in 1 SYRINGE",
      "package_ndc": "17856-1133-8",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260702"
    }
  ],
  "productId": "17856-1133_59f7927f-899d-3af9-e063-6394a90aacbd",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "17856-1133",
  "deaSchedule": null,
  "genericName": "spironolactone",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "SPIRONOLACTONE",
      "strength": "25 mg/5mL"
    }
  ],
  "applicationNumber": "NDA209478",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20231031",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175557",
      "N0000011310"
    ],
    "unii": [
      "27O7W4T232"
    ],
    "rxcui": [
      "104232"
    ],
    "spl_set_id": [
      "122558a0-57bb-4195-9adf-d37b049cbfb5"
    ],
    "pharm_class_epc": [
      "Aldosterone Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Aldosterone Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "ATLANTIC BIOLOGICALS CORP."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:17856-1133_59f7927f-899d-3af9-e063-6394a90aacbd"